Phinn SRL
2.6 FTEThe score of Phinn shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +6 % Headcount (avg FTE) +13 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Phinn's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −8,671 € | ||||
| Equity | −14,558 € | ||||
| Cash | 40,533 € | ||||
| EBITDA | 21,081 € | ||||
| Total assets | 885,031 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 05 Jan 2026
- Year ended 30 Jun 2024filed on 03 Mar 2025
- Year ended 30 Jun 2023filed on 14 Dec 2023
- Year ended 30 Jun 2022filed on 13 Dec 2022
- Year ended 30 Jun 2021filed on 14 Dec 2021
Phinn's financial analysis
- Solvency-1.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Phinn
Phinn's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0846.340.341
- VAT number
- BE0846340341
- Peppol
- Registered · 0208:0846340341 · as of 04 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Jun 2012
- Registered office
- 9255 Buggenhout
- Size
- Micro · 2.6 FTE
- Latest accounts
- 2025 · filed on 05 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Phinn (SRL) has been based in Buggenhout since 2012, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 8,671 € and equity of −14,558 €; its revenue is not published. With 2.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -1.6%, below the median of its sector (44.2%).
Companies similar to Phinn
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Centrum Schelle Retail sale of pharmaceutical products Schelle · balance sheet 885,048 €
- Cobra Apotheek Rosselaar Retail sale of pharmaceutical products Mol · balance sheet 884,462 €
- Pharma-Thim Retail sale of pharmaceutical products Genappe · balance sheet 883,008 €
- DE Vulder Retail sale of pharmaceutical products Roosdaal · balance sheet 887,085 €
- Pharmacie des Citronniers Retail sale of pharmaceutical products Brussels · balance sheet 882,658 €
- Apoteek Dreezen Retail sale of pharmaceutical products Hasselt · balance sheet 882,214 €
- Pharmavrai Retail sale of pharmaceutical products Huy · balance sheet 880,268 €
- Lo Farma Retail sale of pharmaceutical products Lochristi · balance sheet 875,320 €
Frequently asked questions about Phinn
What is the revenue of Phinn?
Phinn files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Phinn?
In Belgium, the VAT number is the company number prefixed with BE: BE0846340341 for Phinn, if the company is VAT-registered. Its company number (CBE) is 0846.340.341.
Where is the registered office of Phinn?
According to the CBE register, the registered office of Phinn is in 9255 Buggenhout.
What is the equity of Phinn?
At the close of the 2025 financial year, the equity of Phinn amounts to -14,558 €, a solvency of -1.6% of total assets.
How many people work at Phinn?
2.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Phinn?
The register lists 1 active mandates at Phinn. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Phinn
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →